XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature

Journal: Nature Communications

Published: 2020-11-17

DOI: 10.1038/s41467-020-19633-9

Affiliations: 4

Authors: 6

Go to article
Institutions Share
Predictive Biomarkers and Novel Therapeutic Strategies in Oncology, France 0.50
Nazarbayev University (NU), Kazakhstan 0.17
Molecular Pathology and Virology, IUH, France 0.17
Unité Intégrité du Génome et Cancers, France 0.17